BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND PBX1, P40424, 5087 AND Treatment
10 results:

  • 1. TRIM26 promotes non-small cell lung cancer survival by inducing pbx1 degradation.
    Sun Y; Lin P; Zhou X; Ren Y; He Y; Liang J; Zhu Z; Xu X; Mao X
    Int J Biol Sci; 2023; 19(9):2803-2816. PubMed ID: 37324936
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Targeting SPHK1/pbx1 Axis Induced Cell Cycle Arrest in Non-Small Cell lung cancer.
    Lin Z; Li Y; Han X; Fu Z; Tian Z; Li C
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361531
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Neoaortoiliac system and cryopreserved human allograft for the treatment of aortic graft infections.
    Omran S; Gröger S; Bruder L; Bürger M; Kapahnke S; Haidar H; Konietschke F; Greiner A
    Vascular; 2023 Oct; 31(5):850-857. PubMed ID: 35549485
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Traditional Chinese Medicine in cancer Care: An Overview of 5834 Randomized Controlled Trials Published in Chinese.
    Lu CL; Li X; Zhou HM; Zhang C; Yang YY; Feng RL; Long CJ; Deng FY; Li JC; Cao ZM; Mao QY; Zhu JP; Hong YF; Huang SY; Qiu JY; Liu YX; Wang Y; Yan YQ; Dong JM; Luo YX; Chen YM; Guan YJ; Wieland LS; Robinson N; Liu JP
    Integr Cancer Ther; 2021; 20():15347354211031650. PubMed ID: 34261372
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prophylactic Cranial Irradiation in Patients With High-Risk Metastatic Non-Small Cell lung cancer: Quality of Life and Neurocognitive Analysis of a Randomized Phase II Study.
    Maldonado F; Gonzalez-Ling A; Oñate-Ocaña LF; Cabrera-Miranda LA; Zatarain-Barrón ZL; Turcott JG; Flores-Estrada D; Lozano-Ruiz F; Cacho-Díaz B; Arrieta O
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):81-92. PubMed ID: 33915217
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Improving quality of life in patients with metastatic prostate cancer following one cycle of 177Lu-PSMA-617 radioligand therapy: a pilot study.
    Marinova M; Alamdar R; Ahmadzadehfar H; Essler M; Attenberger U; Mücke M; Conrad R
    Nuklearmedizin; 2020 Dec; 59(6):409-414. PubMed ID: 32823294
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of MMP1 as a potential gene conferring erlotinib resistance in non-small cell lung cancer based on bioinformatics analyses.
    Zhou H; Xiang Q; Hu C; Zhang J; Zhang Q; Zhang R
    Hereditas; 2020 Jul; 157(1):32. PubMed ID: 32703314
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Is there an oligometastatic state in pancreatic cancer? Practical clinical considerations raise the question.
    Scorsetti M; Comito T; Franceschini D; Franzese C; Prete MG; D'Alessio A; Bozzarelli S; Rimassa L; Santoro A
    Br J Radiol; 2020 Feb; 93(1106):20190627. PubMed ID: 31825664
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review.
    Amini A; Yeh N; Gaspar LE; Kavanagh B; Karam SD
    Radiat Oncol; 2014 Sep; 9():210. PubMed ID: 25239200
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non-small cell lung carcinoma.
    Qiu Y; Morii E; Tomita Y; Zhang B; Matsumura A; Kitaichi M; Okumura M; Aozasa K
    Cancer Sci; 2009 Jul; 100(7):1198-209. PubMed ID: 19356220
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.